Nov 15, 2018
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.27 to $5.32.
The split itself did not change the total investment value.
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) operates in the Biotechnology industry.
DiaMedica Therapeutics Inc. company overviewDiaMedica Therapeutics Inc.'s most recent stock split was on November 15, 2018. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
DiaMedica Therapeutics Inc. has split its stock once. This history records one reverse split, on November 15, 2018.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In DiaMedica Therapeutics Inc.'s 1-for-20 reverse split on November 15, 2018, every 20 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
DiaMedica Therapeutics Inc. has not announced a new split in our records. Its most recent split was on November 15, 2018, 7 years ago. Companies announce splits in advance, and any new NASDAQ:DMAC split will appear on this page.